Neuropace, Inc. Common Stock
Symbol: NPCE (NASDAQ)
10.01
▲ (3.52%) 0.340
Company Description:
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
Key Stats
- Today's Open: $9.67
- Today's High: $10.105
- Today's Low: $9.6
- Today's Volume: 114.95K
- Yesterday Close: $9.67
- Yesterday High: $10.2352
- Yesterday Low: $9.6
- Yesterday Volume: 161.04K
- Last Min Volume: 2
- Last Min High: $10.01
- Last Min Low: $10.01
- Last Min VWAP: $10.01
Company Profile
- Name: Neuropace, Inc. Common Stock
- Website: https://www.neuropace.com
- Listed Date: 2021-04-22
- Location: MOUNTAIN VIEW, CA
- Market Status: Active
- CIK Number: 0001528287
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $319.90M
- Round Lot: 100
- Outstanding Shares: 33.08M
- Asset Type: CS
RECENT FILINGS FOR NPCE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 4 | View |
| 2025-09-03 | SCHEDULE 13G/A | View |
| 2025-08-28 | 4 | View |
| 2025-08-28 | 4 | View |
| 2025-08-22 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-05 | SCHEDULE 13G/A | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 3 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 8-K | View |
| 2025-06-12 | 8-K | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
Latest News on NPCE